Steven Shulman - Magellan Health Independent Director
Director
Mr. Steven J. Shulman is Chairman of the Board of the Company. He serves as the managing partner at Shulman Family Ventures, Inc., a healthcare private equity firm. He previously served as an operating partner at Water Street Healthcare Partners, LLC, a healthcarefocused private equity firm, from 2008 until March 2015 and Tower Three Partners LLC, from 2008 until 2013. From 2002 to 2008, Mr. Shulman served as chairman and chief executive officer of Magellan Health Services, Inc., where he spearheaded its turnaround and restructuring following bankruptcy. Mr. Shulman previously served as chairman and chief executive officer of Internet Healthcare Group, LLC and as chairman, president and chief executive officer of Prudential Healthcare, Inc., a healthcare insurer. Prior to that, Mr. Shulman served in senior executive positions at Value Health, Inc., a specialty managed care company he founded and took public. Mr. Shulman currently serves as chairman of both Quartet Health, Inc., a healthcare technology company which connects primary care and mental health providers and CareCentrix, Inc., a postacute managed care company. He also serves as a director of several other privatelyheld companies, including VillageMD, a national provider of primary care Facet, a medical device company and Pager, Inc., a mobile healthcare technology company. Mr. Shulman was appointed to the board in March 2019 and was nominated for election to the company board for the first time due to his extensive expertise in private equity investment and the healthcare industry, as the former chairman and chief executive officer of the company. since 2019.
Age | 64 |
Tenure | 5 years |
Phone | 800 642-1716 |
Web | www.magellanhealth.com |
Magellan Health Management Efficiency
The company has return on total asset (ROA) of 0.54 % which means that it generated a profit of $0.54 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health's management efficiency ratios could be used to measure how well Magellan Health manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 562.64 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Magellan Health has a current ratio of 2.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Magellan Health until it has trouble settling it off, either with new capital or with free cash flow. So, Magellan Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Magellan Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Magellan to invest in growth at high rates of return. When we think about Magellan Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Frederick Stratton | Weyco Group | 78 | |
Kimbal Musk | Tesla Inc | 45 | |
Larry Jobe | Mannatech Incorporated | 74 | |
Eric Schrier | Mannatech Incorporated | 62 | |
Ravichandra Saligram | Church Dwight | 64 | |
Antonio Gracias | Tesla Inc | 47 | |
Lawrence Ellison | Tesla Inc | 73 | |
Ira Ehrenpreis | Tesla Inc | 49 | |
James Murdoch | Tesla Inc | 45 | |
Gary Ellis | Toro Co | 64 | |
Bradley Buss | Tesla Inc | 54 | |
Michael Vale | Toro Co | 54 | |
Linda Ferrell | Mannatech Incorporated | 55 | |
Stephen Jurvetson | Tesla Inc | 51 | |
Jeffrey Harmening | Toro Co | 53 | |
Robert LeBlanc | Church Dwight | 68 | |
Katherine Harless | Toro Co | 69 | |
Robert Feitler | Weyco Group | 86 | |
Jeffrey Ettinger | Toro Co | 62 | |
Kevin Robbins | Mannatech Incorporated | N/A | |
James ORourke | Toro Co | 60 |
Management Performance
Return On Equity | -0.16 | |||
Return On Asset | 0.54 |
Magellan Health Leadership Team
Elected by the shareholders, the Magellan Health's board of directors comprises two types of representatives: Magellan Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Magellan. The board's role is to monitor Magellan Health's management team and ensure that shareholders' interests are well served. Magellan Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Magellan Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eran Broshy, Independent Director | ||
Swati Abbott, Director | ||
Mostafa Kamal, Senior Vice President and General Manager | ||
Scott MacKenzie, Independent Director | ||
Barry Smith, Chairman and CEO | ||
Mary Sammons, Independent Director | ||
Joe Bogdan, Senior Vice President Corporate Finance | ||
Steven Shulman, Independent Director | ||
Matthew Simas, Director | ||
Perry Fine, Independent Director | ||
Daniel Gregoire, General Counsel and Secretary | ||
Kay James, Director | ||
Srinivas Koushik, CTO | ||
Leslie Norwalk, Independent Director | ||
John Agwunobi, Independent Director | ||
John Littel, Senior Vice President - Government Affairs and Communications | ||
Michael Diament, Independent Director | ||
William McBride, Independent Director | ||
Guy Sansone, Independent Director | ||
Peter Feld, Independent Director | ||
Renie Shapiro, Senior Vice President Corporate Finance | ||
Michael Ressner, Independent Director | ||
Sanjeev Srivastava, CEO of Magellan Healthcare | ||
Caskie LewisClapper, Chief Human Resource Officer |
Magellan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Magellan Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.16 | |||
Return On Asset | 0.54 | |||
Profit Margin | 6.26 % | |||
Operating Margin | 0.60 % | |||
Current Valuation | 2.09 B | |||
Shares Outstanding | 26.33 M | |||
Shares Owned By Insiders | 1.64 % | |||
Shares Owned By Institutions | 98.36 % | |||
Number Of Shares Shorted | 1.16 M | |||
Price To Earning | 8.49 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Magellan Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Magellan Health's short interest history, or implied volatility extrapolated from Magellan Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Magellan Stock
If you are still planning to invest in Magellan Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magellan Health's history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |